糖尿病中的代谢、结构和生化改变与心力衰竭的发生
本综述探讨糖尿病通过代谢、结构和生化改变促进心力衰竭发生的机制。糖尿病的高脂血症、高血糖和胰岛素抵抗状态改变心脏能量代谢,增加脂肪酸依赖并降低葡萄糖氧化速率;细胞外基质重塑导致心肌纤维化,钙处理受损引起收缩功能障碍;脂毒性和糖毒性损害血管功能、心肌收缩力、钙信号、氧化应激、心脏效率和脂性凋亡;蛋白质乙酰化、蛋白质甲基化和DNA甲基化改变影响基因表达和蛋白质活性。这些改变共同导致心脏效率降低、对缺血损伤的易感性增加以及心力衰竭发生风险增加。
要点
- 糖尿病通过代谢、结构和生化改变促进心力衰竭发生,独立于缺血性心脏病。
- 糖尿病高脂血症、高血糖和胰岛素抵抗状态使心脏增加脂肪酸依赖并降低葡萄糖氧化速率。
- 细胞外基质重塑导致心肌纤维化,钙处理受损引起心脏收缩功能障碍。
核心结论
- 糖尿病通过多种代谢、结构和生化改变导致心脏效率降低、对缺血损伤的易感性增加以及心力衰竭发生风险增加。
研究设计与样本
- 综述,探讨糖尿病中代谢、结构和生化改变促进心力衰竭发生的机制。
主要发现
- 糖尿病的高脂血症、高血糖和胰岛素抵抗状态改变心脏能量代谢,增加脂肪酸依赖并降低葡萄糖氧化速率。
- 细胞外基质重塑导致心肌纤维化,钙处理受损引起心脏收缩功能障碍。
- 脂毒性和糖毒性损害血管功能、心肌收缩力、钙信号、氧化应激、心脏效率和脂性凋亡。
- 蛋白质乙酰化、蛋白质甲基化和DNA甲基化改变引起基因表达和蛋白质活性改变。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diabetes contributes to the development of heart failure through various metabolic, structural and biochemical changes. The presence of diabetes increases the risk for the development of cardiovascular disease (CVD), and since the introduction of cardiovascular outcome trials to test diabetic drugs, the importance of improving our understanding of the mechanisms by which diabetes increases the risk for heart failure has come under the spotlight. In addition to the coronary vasculature changes that predispose individuals with diabetes to coronary artery disease, diabetes can also lead to cardiac dysfunction independent of ischaemic heart disease. The hyperlipidaemic, hyperglycaemic and insulin resistant state of diabetes contributes to a perturbed energy metabolic milieu, whereby the heart increases its reliance on fatty acids and decreases glucose oxidative rates. In addition to changes in cardiac energy metabolism, extracellular matrix remodelling contributes to the development of cardiac fibrosis, and impairments in calcium handling result in cardiac contractile dysfunction. Lipotoxicity and glucotoxicity also contribute to impairments in vascular function, cardiac contractility, calcium signalling, oxidative stress, cardiac efficiency and lipoapoptosis. Lastly, changes in protein acetylation, protein methylation and DNA methylation contribute to a myriad of gene expression and protein activity changes. Altogether, these changes lead to decreased cardiac efficiency, increased vulnerability to an ischaemic insult and increased risk for the development of heart failure. This review explores the above mechanisms and the way in which they contribute to cardiac dysfunction in diabetes.
引用
- Ho KL, Karwi QG, Connolly D, et al. Metabolic, structural and biochemical changes in diabetes and the development of heart failure. Diabetologia. 2022. PMID: 34994805. doi:10.1007/s00125-021-05637-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。